Wessanen Trading update Q3 2016: Sustaining profitable growth
(Thomson Reuters ONE) -
Trading update Q3 2016: Sustaining profitable growth
Q3 2016 highlights
* Total reported revenue growth 9.2% (8.8% YTD)
* Own brands autonomous growth 7.4% (9.2% YTD)
* Total autonomous revenue growth 3.9% (7.0% YTD) due to accelerated decline
of private label business
* EBITE margin of 7.3% despite significant increase in A&P. YTD EBITE margin
is up 90bps to 8.3%
* Integration of Piramide, Ineobio and Mrs Crimbles fully on track
CEO Statement
We have sustained our good growth momentum on own brands in Q3 and YTD growth
stands at 9.2%. Autonomous revenue growth for total Wessanen remains at the
upper end of our guidance range of 5-7% year to date, despite an accelerated
decline of private label business in Q3. YTD EBITE has increased by 22.4% and
margin is up 90bps to 8.3%. In the quarter we achieved an EBITE margin of 7.3%
despite investing significantly more A&P into our brands. Integration plans of
Piramide, Inebio and Mrs Crimbles are being executed as planned.
We are on track to deliver a good 2016 result both in terms of growth and profit
as we are further strengthening our brands in a growing market for healthier and
more sustainable food.
Guidance FY 2016
* Total autonomous revenue growth at the upper end of our long term guidance
range of 5-7%
* We expect to report:
* a higher EBITE in 2016 versus 2015
* an increase of the EBITE % of revenue
* Net financing costs around ?1-2 million
* Tax rate of around 30%
* Capital expenditures ?8-9 million
* Depreciation and amortisation ?7-8 million
Analyst & investor meeting
At 10h00 CET, a conference call for analysts, investors, and media will be
hosted by Ronald Merckx (CFO). The dial-in number is +31 20 703 8261 (toll free
0800 023 1436) - please quote "Wessanen". There will also be a live audio
webcast via www.wessanen.com.
The press release and presentation are available for download at
www.wessanen.com.
Media, investor & analyst enquiries
Ronald Merckx (CFO)
Phone +31 20 3122 124
Ronald.Merckx(at)wessanen.com
Important dates
16-11-2016 Capital Markets Day (Italy)
15-02-2017 Publication Q4 2016 results
For PDF click here:
http://hugin.info/143317/R/2050972/767279.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Wessanen via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 25.10.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 502470
Anzahl Zeichen: 3087
contact information:
Town:
AT Amsterdam Zuidoost
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 264 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Wessanen Trading update Q3 2016: Sustaining profitable growth"
steht unter der journalistisch-redaktionellen Verantwortung von
Wessanen (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).




![Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters](/modules/PresseInfo/thump/fp_fwd.gif)
